Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 973 | 873 | 973 | 916 | 1173 | 1874 |
Fund Return | -2.69% | -12.67% | -2.69% | -2.9% | 3.23% | 6.48% |
Place in category | 708 | 819 | 708 | 301 | 282 | 99 |
% in Category | 73 | 84 | 73 | 47 | 58 | 30 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Wellington Global Health Care EquiD | 2.06B | 4.56 | 0.72 | 6.80 | ||
Wellington Global Health Care EquUG | 2.06B | 5.66 | 1.88 | 8.04 | ||
Wellington Global Health Care EquiN | 2.06B | 5.18 | 1.37 | 7.49 | ||
Wellington Enduring Assets Fund USD | 553.94M | 21.47 | 7.16 | 6.95 | ||
Wellington Emerging Markets EquityT | 35M | 8.35 | -2.62 | 4.74 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Global Life Sciences Fund A U | 3.98B | 10.19 | 5.78 | 7.55 | ||
Janus Global Life Sciences Fund I U | 3.98B | 11.02 | 6.65 | 8.39 | ||
Wellington Global Health Care EquiD | 2.06B | 4.56 | 0.72 | 6.80 | ||
Wellington Global Health Care EquUG | 2.06B | 5.66 | 1.88 | 8.04 | ||
Wellington Global Health Care EquiN | 2.06B | 5.18 | 1.37 | 7.49 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 9.16 | 811.08 | -1.48% | |
UnitedHealth | US91324P1021 | 7.88 | 542.49 | -0.56% | |
Novo Nordisk B | DK0062498333 | 5.55 | 607.3 | +0.60% | |
Merck&Co | US58933Y1055 | 4.42 | 98.82 | -0.13% | |
AstraZeneca | GB0009895292 | 4.17 | 11,344.0 | +0.27% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Sell | Neutral |
Summary | Strong Buy | Neutral | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review